pravastatin has been researched along with Cicatrix, Hypertrophic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, X; Dolivo, DM; Galiano, RD; Hong, SJ; Jia, S; Mustoe, TA; Salcido, J; Xie, P | 1 |
Hong, SJ; Kim, PS; Ko, JH; Mustoe, TA; Zhao, Y | 1 |
2 other study(ies) available for pravastatin and Cicatrix, Hypertrophic
Article | Year |
---|---|
Liposome-encapsulated statins reduce hypertrophic scarring through topical application.
Topics: Animals; Cicatrix, Hypertrophic; Collagen Type I; Collagen Type III; Connective Tissue Growth Factor; Ear, External; Erythema; Fibroblasts; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Liposomes; Melanins; Platelet Endothelial Cell Adhesion Molecule-1; Pravastatin; Rabbits; Simvastatin; Skin; Spectrophotometry | 2020 |
HMG-CoA reductase inhibitors (statins) reduce hypertrophic scar formation in a rabbit ear wounding model.
Topics: Animals; Cicatrix, Hypertrophic; Disease Models, Animal; Ear; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Rabbits; Simvastatin; Wound Healing | 2012 |